Altered expression of miRNAs in a dihydrotestosterone-induced rat PCOS model

Journal of Ovarian Research

Volumn 6, Issue 1, 2013, Pages

  Hossain, Md Munir ^a,b   Cao, Mingju ^c   Wang, Qi ^c   Kim, Ji Young ^c   Schellander, Karl ^a   Tesfaye, Dawit ^a   Tsang, Benjamin K ^c,d,e  

^a UNIVERSITY OF BONN   (Germany)

^b BANGLADESH AGRICULTURAL UNIVERSITY   (Bangladesh)

^c UNIVERSITY OF OTTAWA   (Canada)

^d Seoul National University   (South Korea)

^e OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Dihydrotestosterone; miRNA; PCOS

Indexed keywords

ALDOSTERONE; ANDROGEN; ANDROSTANOLONE; CALCIUM; ESTROGEN; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR; FOCAL ADHESION KINASE 1; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID RECEPTOR; GROWTH HORMONE; INOSITOL PHOSPHATE; INSULIN; MICRORNA; PROTEIN 14 3 3; PROTEIN P53; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; VASCULOTROPIN;

ANDROGEN METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOVULATION; APOPTOSIS; ARTICLE; CALCIUM SIGNALING; COMPUTER MODEL; CONTROLLED STUDY; ESTROGEN METABOLISM; ESTRUS CYCLE; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; HOMEOSTASIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; NONHUMAN; OVARY CANCER; OVARY FOLLICLE; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; THECA CELL; WEIGHT GAIN;

EID: 84879117673     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-6-36     Document Type: Article

References (59)

1. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Dunaif A, Endocr Rev 1997 18 774 800 10.1210/er.18.6.774 9408743
2. Polycystic ovary syndrome. Franks S, N Engl J Med 1995 333 853 861 10.1056/NEJM199509283331307 7651477
3. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA, Gosman GG, Nestler JE, Giudice LC, Leppert PC, Myers ER, N Engl J Med 2007 356 551 566 10.1056/NEJMoa063971 17287476
4. Polycystic ovary syndrome. Guzick DS, Obstet Gynecol 2004 103 181 193 10.1097/01.AOG.0000104485.44999.C6 14704263
5. The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray. Diao FY, Xu M, Hu Y, Li J, Xu Z, Lin M, Wang L, Zhou Y, Zhou Z, Liu J, Sha J, J Mol Endocrinol 2004 33 59 72 10.1677/jme.0.0330059 15291743
6. The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. Wood JR, Nelson VL, Ho C, Jansen E, Wang CY, Urbanek M, McAllister JM, Mosselman S, Strauss JF III, J Biol Chem 2003 278 26380 26390 10.1074/jbc.M300688200 12734205
7. Genomic and post-genomic approaches to polycystic ovary syndrome-progress so far: Mini Review. Hughes C, Elgasim M, Layfield R, Atiomo W, Hum Reprod 2006 21 2766 2775 10.1093/humrep/del222 16936300
8. The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling. Wood JR, Ho CK, Nelson-Degrave VL, McAllister JM, Strauss JF III, J Reprod Immunol 2004 63 51 60 10.1016/j.jri.2004.01.010 15284005
9. Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. Wood JR, Dumesic DA, Abbott DH, Strauss JF III, J Clin Endocrinol Metab 2007 92 705 713 17148555
10. Cloning and expression profiling of small RNAs expressed in the mouse ovary. Ro S, Song R, Park C, Zheng H, Sanders KM, Yan W, RNA 2007 13 2366 2380 10.1261/rna.754207 17951331
11. Maternal microRNAs are essential for mouse zygotic development. Tang F, Kaneda M, O'Carroll D, Hajkova P, Barton SC, Sun YA, Lee C, Tarakhovsky A, Lao K, Surani MA, Genes Dev 2007 21 644 648 10.1101/gad.418707 17369397
12. Hormonal regulation of MicroRNA expression in periovulatory mouse mural granulosa cells. Fiedler SD, Carletti MZ, Hong X, Christenson LK, Biol Reprod 2008 79 1030 1037 10.1095/biolreprod.108.069690 18716288
13. MicroRNAs and mammalian ovarian development. Zhao H, Rajkovic A, Semin Reprod Med 2008 26 461 468 10.1055/s-0028-1096126 18951328
14. Identification of microRNAs controlling human ovarian cell proliferation and apoptosis. Sirotkin AV, Laukova M, Ovcharenko D, Brenaut P, Mlyncek M, J Cell Physiol 2009 223 49 56
15. Identification of microRNAs controlling human ovarian cell steroidogenesis via a genome-scale screen. Sirotkin AV, Ovcharenko D, Grossmann R, Laukova M, Mlyncek M, J Cell Physiol 2009 219 415 420 10.1002/jcp.21689 19194990
16. The expression of microRNA (miRNA) mir-23a and 23b and their target gene, CYP19A1 (aromatase) in follicular cells obtained from women undergoing ART. Alford C, Toloubeydokhti T, Al-Katanani Y, Drury KC, Williams R, Chenini N, Fertil Steril 2007 88 166 S167
17. The expression of microRNA (miRNA), mir-17, mir-211 and mir-542 and their target genes, StAR, IL-1b and Cox2 in follicular cells derived from women undergoing ART. Toloubeydokhti T, Alford C, Al-Katanani Y, Luo X, Williams RS, Nasser C, Fertil Steril 2007 88 165 S166
18. Role of microRNAs in obesity and the metabolic syndrome. Heneghan HM, Miller N, Kerin MJ, Obes Rev 2010 11 354 361 10.1111/j.1467-789X.2009.00659.x 19793375
19. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, Jacobs HS, Hum Reprod 1995 10 2107 2111 8567849
20. Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome. Wachs DS, Coffler MS, Malcom PJ, Shimasaki S, Chang RJ, J Clin Endocrinol Metab 2008 93 1827 1833 10.1210/jc.2007-2664 18285408
21. Dehydroepiandrosterone to induce murine models for the study of polycystic ovary syndrome. Motta AB, J Steroid Biochem Mol Biol 2010 119 105 111 10.1016/j.jsbmb.2010.02.015 20188831
22. Rat models of polycystic ovary syndrome. Singh KB, Sourcebook of models for biomedical research Totowa, New Jersey: Humana Press Inc, Conn PM, 2008 405 410
23. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Manneras L, Cajander S, Holmang A, Seleskovic Z, Lystig T, Lonn M, Stener-Victorin E, Endocrinology 2007 148 3781 3791 10.1210/en.2007-0168 17495003
24. Effects of long term androgen and estradiol exposure on the hypothalamus. Brawer J, Schipper H, Robaire B, Endocrinology 1983 112 194 199 10.1210/endo-112-1-194 6401175
25. Determination of the estrous cycle phases of rats: some helpful considerations. Marcondes FK, Bianchi FJ, Tanno AP, Braz J Biol 2002 62 609 614 10.1590/S1519-69842002000400008 12659010
26. Effect of Withania somnifera on insulin sensitivity in non-insulin-dependent diabetes mellitus rats. Anwer T, Sharma M, Pillai KK, Iqbal M, Basic Clin Pharmacol Toxicol 2008 102 498 503 10.1111/j.1742-7843.2008. 00223.x 18346053
27. Ovarian follicle counts-not as simple as 1, 2, 3. Tilly JL, Reprod Biol Endocrinol 2003 1 11 10.1186/1477-7827-1-11 12646064
28. Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections. Obernosterer G, Martinez J, Alenius M, Nat Protoc 2007 2 1508 1514 10.1038/nprot.2007.153 17571058
29. Identification and characterization of miRNAs expressed in the bovine ovary. Hossain MM, Ghanem N, Hoelker M, Rings F, Phatsara C, Tholen E, Schellander K, Tesfaye D, BMC Genomics 2009 10 443 10.1186/1471-2164-10-443 19765282
30. MicroRNA expression and identification of putative miRNA targets in ovarian cancer. Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, Shih Ie M, Zhang Y, Wood W III, Becker KG, Morin PJ, PLoS One 2008 3 2436 10.1371/journal.pone.0002436 18560586
31. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Giannakakis A, Sandaltzopoulos R, Greshock J, Liang S, Huang J, Hasegawa K, Li C, O'Brien-Jenkins A, Katsaros D, Weber BL, Simon C, Coukos G, Zhang L, Cancer Biol Ther 2008 7 255 264 10.4161/cbt.7.2.5297 18059191
32. Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M, Finn SP, Barrett C, Loda M, Gleeson N, D'Arcy T, McGuinness E, Sheils O, Sheppard B, O'Leary J, Mol Cancer 2008 7 35 10.1186/1476-4598-7-35 18442408
33. MicroRNA expression profiles in serous ovarian carcinoma. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, Kim JW, Kim S, Clin Cancer Res 2008 14 2690 2695 10.1158/1078-0432.CCR-07-1731 18451233
34. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, Liu CG, Giannakakis A, Alexiou P, Hasegawa K, Johnstone CN, Megraw MS, Adams S, Lassus H, Huang J, Kaur S, Liang S, Sethupathy P, Leminen A, Simossis VA, Sandaltzopoulos R, Naomoto Y, Katsaros D, Gimotty PA, DeMichele A, Huang Q, Butzow R, Rustgi AK, Weber BL, Birrer MJ, Hatzigeorgiou AG, Croce CM, Coukos G, Proc Natl Acad Sci U S A 2008 105 7004 7009 10.1073/pnas.0801615105 18458333
35. Androgen receptor gene expression in rat granulosa cells: the role of follicle-stimulating hormone and steroid hormones. Tetsuka M, Hillier SG, Endocrinology 1996 137 4392 4397 10.1210/en.137.10.4392 8828500
36. A network of miRNAs expressed in the ovary are regulated by FSH. Yao N, Lu CL, Zhao JJ, Xia HF, Sun DG, Shi XQ, Wang C, Li D, Cui Y, Ma X, Front Biosci 2009 14 3239 3245 19273269
37. Follicle-stimulating hormone regulation of microRNA expression on progesterone production in cultured rat granulosa cells. Yao N, Yang BQ, Liu Y, Tan XY, Lu CL, Yuan XH, Ma X, Endocrine 2010 38 158 166 10.1007/s12020-010-9345- 1 20734245
38. Increased ovulation rate in gilts treated with dihydrotestosterone. Cardenas H, Herrick JR, Pope WF, Reproduction 2002 123 527 533 10.1530/rep.0.1230527 11914115
39. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Lowery AJ, Miller N, Devaney A, McNeill RE, Davoren PA, Lemetre C, Benes V, Schmidt S, Blake J, Ball G, Kerin MJ, Breast Cancer Res 2009 11 27 10.1186/bcr2257 19432961
40. Androgen and estrogen receptors in the cytosol from male rat anterior hypophysis: further characteristics and differentiation between androgen and estrogen receptors. Mercier L, le Guellec C, Thieulant ML, Samperez S, Jouan P, J Steroid Biochem 1976 7 779 785 10.1016/0022-4731(76)90179-5 1011836
41. MicroRNA expression and regulation in human ovarian carcinoma cells by luteinizing hormone. Cui J, Eldredge JB, Xu Y, Puett D, PLoS One 2011 6 21730 10.1371/journal.pone.0021730 21765906
42. Expression of G1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats. Chen Y, Robles AI, Martinez LA, Liu F, Gimenez-Conti IB, Conti CJ, Cell Growth Differ 1996 7 1571 1578 8930407
43. The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. Mercatelli N, Coppola V, Bonci D, Miele F, Costantini A, Guadagnoli M, Bonanno E, Muto G, Frajese GV, De Maria R, Spagnoli LG, Farace MG, Ciafre SA, PLoS One 2008 3 4029 10.1371/journal.pone. 0004029 19107213
44. The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. Sun T, Wang Q, Balk S, Brown M, Lee GS, Kantoff P, Cancer Res 2009 69 3356 3363 10.1158/0008-5472.CAN-08-4112 19351832
45. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, Ciafre SA, Farace MG, J Biol Chem 2007 282 23716 23724 10.1074/jbc.M701805200 17569667
46. Estrogen receptor alpha and beta expression in theca and granulosa cells from women with polycystic ovary syndrome. Jakimiuk AJ, Weitsman SR, Yen HW, Bogusiewicz M, Magoffin DA, J Clin Endocrinol Metab 2002 87 5532 5538 10.1210/jc.2002-020323 12466349
47. The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, Thiruchelvam P, Barton G, Jiao LR, Wait R, Waxman J, Hannon GJ, Stebbing J, Proc Natl Acad Sci U S A 2009 106 15732 15737 10.1073/pnas. 0906947106 19706389
48. MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, Coppola D, Cheng JQ, J Biol Chem 2008 283 31079 31086 10.1074/jbc.M806041200 18790736
49. Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer. Zhao Y, Deng C, Wang J, Xiao J, Gatalica Z, Recker RR, Xiao GG, Breast Cancer Res Treat 2010 127 69 80 20535543
50. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, Barbosa-Morais NL, Teschendorff AE, Green AR, Ellis IO, Tavare S, Caldas C, Miska EA, Genome Biol 2007 8 214 10.1186/gb-2007-8-10-r214 17922911
51. Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant microRNA expression. Kovalchuk O, Tryndyak VP, Montgomery B, Boyko A, Kutanzi K, Zemp F, Warbritton AR, Latendresse JR, Kovalchuk I, Beland FA, Pogribny IP, Cell Cycle 2007 6 2010 2018 10.4161/cc.6.16.4549 17700064
52. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK, Fedele V, Ginzinger D, Getts R, Haqq C, Mol Cancer 2006 5 24 10.1186/1476-4598-5-24 16784538
53. Dysregulated miR-183 inhibits migration in breast cancer cells. Lowery AJ, Miller N, Dwyer RM, Kerin MJ, BMC Cancer 2010 10 502 10.1186/1471-2407-10- 502 20858276
54. Testosterone induces redistribution of forkhead box-3a and down-regulation of growth and differentiation factor 9 messenger ribonucleic acid expression at early stage of mouse folliculogenesis. Yang JL, Zhang CP, Li L, Huang L, Ji SY, Lu CL, Fan CH, Cai H, Ren Y, Hu ZY, Gao F, Liu YX, Endocrinology 2010 151 774 782 10.1210/en.2009-0751 20032061
55. Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. Lin H, Dai T, Xiong H, Zhao X, Chen X, Yu C, Li J, Wang X, Song L, PLoS One 2010 5 15797 10.1371/journal.pone. 0015797 21203424
56. MicroRNAs: genomics, biogenesis, mechanism, and function. Bartel DP, Cell 2004 116 281 297 10.1016/S0092-8674(04)00045-5 14744438
57. Potential regulatory functions of microRNAs in the ovary. Toloubeydokhti T, Bukulmez O, Chegini N, Semin Reprod Med 2008 26 469 478 10.1055/s-0028- 1096127 18951329
58. Transforming growth factor-beta-regulated miR-24 promotes skeletal muscle differentiation. Sun Q, Zhang Y, Yang G, Chen X, Cao G, Wang J, Sun Y, Zhang P, Fan M, Shao N, Yang X, Nucleic Acids Res 2008 36 2690 2699 10.1093/nar/gkn032 18353861
59. Combinatorial microRNA target predictions. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N, Nat Genet 2005 37 495 500 10.1038/ng1536 15806104